Patents by Inventor Yu-Fen Liu

Yu-Fen Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for improving immunity in shrimps
    Patent number: 11856971
    Abstract: The invention discloses a method for improving immunity in shrimps, by administering an extract of cocoa rind to a shrimp body to improve immunity of the shrimp body. The extract of cocoa rind is obtained by extracting a dried sample of cocoa rind by an aqueous ethanol solution with a concentration of ethanol being 90-98%. The dried sample of cocoa rind has a water content of 2-5%.
    Type: Grant
    Filed: July 10, 2019
    Date of Patent: January 2, 2024
    Assignee: NATIONAL PINGTUNG UNIVERSITY OF SCIENCE & TECHNOLOGY
    Inventors: Wen-Teng Cheng, Wan-Lin Tsai, Hsin-Wei Kuo, Yu-Fen Liu, Chin-Chyuan Chang, Yu-Hung Lin
  • METHOD FOR IMPROVING IMMUNITY IN SHRIMPS
    Publication number: 20200305467
    Abstract: The invention discloses a method for improving immunity in shrimps, by administering an extract of cocoa rind to a shrimp body to improve immunity of the shrimp body. The extract of cocoa rind is obtained by extracting a dried sample of cocoa rind by an aqueous ethanol solution with a concentration of ethanol being 90-98%. The dried sample of cocoa rind has a water content of 2-5%.
    Type: Application
    Filed: July 10, 2019
    Publication date: October 1, 2020
    Inventors: WEN-TENG CHENG, WAN-LIN TSAI, HSIN-WEI KUO, YU-FEN LIU, CHIN-CHYUAN CHANG, YU-HUNG LIN
  • Methods and compositions relating to COL2A1 gene mutations and osteonecrosis
    Patent number: 7718366
    Abstract: Methods, compounds, and kits for the diagnosis or screening of osteonecrosis are described, and the development of animal models for COL2A1 function in osteonecrosis is put forth. Novel mutations in the COL2A1 gene are identified that are associated with avascular necrosis of the femoral head. Methods of treatment of osteonecrosis and avascular necrosis of the femoral head, including gene therapy approaches comprising introduction of COL2A1 nucleic acid are contemplated.
    Type: Grant
    Filed: August 12, 2005
    Date of Patent: May 18, 2010
    Assignee: National Health Research Institutes
    Inventors: Shih-Feng Tsai, Yu-Fen Liu, Wei-Ming Chen
  • Methods and compositions relating to COL2A1 gene mutations and osteonecrosis
    Publication number: 20060051794
    Abstract: Methods, compounds, and kits for the diagnosis or screening of osteonecrosis are described, and the development of animal models for COL2A1 function in osteonecrosis is put forth. Novel mutations in the COL2A1 gene are identified that are associated with avascular necrosis of the femoral head. Methods of treatment of osteonecrosis and avascular necrosis of the femoral head, including gene therapy approaches comprising introduction of COL2A1 nucleic acid are contemplated.
    Type: Application
    Filed: August 12, 2005
    Publication date: March 9, 2006
    Inventors: Shih-Feng Tsai, Yu-Fen Liu, Wei-Ming Chen